Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion

[1]  Y. Choi,et al.  Macrovascular invasion is not an absolute contraindication for living donor liver transplantation , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  S. Lee.  A Complete Treatment of Adult Living Donor Liver Transplantation: A Review of Surgical Technique and Current Challenges to Expand Indication of Patients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  B. Choi,et al.  2014 KLCSG-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma: HCC Diagnostic Algorithm , 2014, Digestive Diseases.

[4]  Lunan Yan,et al.  Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria , 2013, Journal of Gastrointestinal Surgery.

[5]  W. Lau,et al.  Surgical Resection Versus Conformal Radiotherapy Combined With TACE for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study , 2013, World Journal of Surgery.

[6]  H. Won,et al.  Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. , 2012, International journal of radiation oncology, biology, physics.

[7]  H. Shirato,et al.  Efficacy of therapy for advanced hepatocellular carcinoma: Intra‐arterial 5‐fluorouracil and subcutaneous interferon with image‐guided radiation , 2011, Journal of gastroenterology and hepatology.

[8]  W. Lau,et al.  Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study , 2011, Annals of Surgical Oncology.

[9]  D. Sze,et al.  Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  K. Sugimachi,et al.  Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation , 2009, Transplantation.

[11]  L. Bolondi,et al.  Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  W. Chapman,et al.  Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation , 2008, Annals of surgery.

[13]  K. Sung,et al.  Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large‐volume center , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  S. Uemoto,et al.  Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  M. Makuuchi,et al.  Living Donor Liver Transplantation for Hepatocellular Carcinoma: Tokyo University Series , 2007, Digestive Diseases.

[16]  J. Joh,et al.  HCC in Living Donor Liver Transplantation: Can We Expand the Milan Criteria? , 2007, Digestive Diseases.

[17]  K. Lee,et al.  Liver Transplantation for Hepatocellular Carcinoma in Patients Who Do Not Meet the Milan Criteria , 2007, Digestive Diseases.

[18]  Y. Maehara,et al.  Extended Indication for Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma , 2007, Transplantation.

[19]  Y. Cho,et al.  The role of 18F‐FDG‐PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients , 2006 .

[20]  G. Otto,et al.  Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  K. Sung,et al.  Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  J. Lee,et al.  Three‐dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma , 2005, Cancer.

[23]  L. Qin,et al.  A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. , 2005, International journal of radiation oncology, biology, physics.

[24]  K. Sugimura,et al.  Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[25]  L. Ferrell,et al.  Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[26]  J. Furuse,et al.  Radiotherapy After Transcatheter Arterial Chemoembolization for Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus , 2002, American journal of clinical oncology.

[27]  A. Venook,et al.  Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.

[28]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[29]  A. Benson,et al.  Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. , 2010, Gastroenterology.

[30]  T. Sauerbruch,et al.  [Sorafenib in advanced hepatocellular carcinoma]. , 2009, Der Internist.

[31]  J. Barkun,et al.  Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[32]  Y. Cho,et al.  The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.